Show me the value! How do US insurers use health economics and real-world evidence?



About the Event

More payers and purchasers in the US are interested in understanding the value of adding new products into their therapeutic portfolios. Often that means presenting them with a value proposition solidly grounded in health economics analysis based on real-world data.

This BioBriefing will present the types of health economics analyses to consider when introducing products to US markets as well as how real-world evidence helps develop a convincing value proposition.